Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.2514 | 1 |
Brugia malayi | Trypsin family protein | 0.0084 | 0.0975 | 0.3369 |
Echinococcus multilocularis | geminin | 0.015 | 0.2276 | 0.2123 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.2157 | 0.8462 |
Mycobacterium ulcerans | beta-lactamase | 0.0043 | 0.0194 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0043 | 0.0194 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0044 | 0.0208 | 0.0063 |
Mycobacterium leprae | Probable lipase LipE | 0.0043 | 0.0194 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0043 | 0.0194 | 0.0407 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.2276 | 0.8971 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0194 | 0.0003 |
Onchocerca volvulus | 0.0084 | 0.0975 | 1 | |
Echinococcus granulosus | CAAX prenyl protease 2 | 0.0162 | 0.2514 | 0.2367 |
Plasmodium vivax | hypothetical protein, conserved | 0.0043 | 0.0194 | 1 |
Brugia malayi | beta-lactamase | 0.0043 | 0.0194 | 0.0003 |
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0162 | 0.2514 | 1 |
Trypanosoma brucei | CAAX amino terminal protease, putative | 0.0162 | 0.2514 | 1 |
Schistosoma mansoni | hypothetical protein | 0.015 | 0.2276 | 0.8971 |
Onchocerca volvulus | 0.0078 | 0.0869 | 0.8641 | |
Mycobacterium leprae | conserved hypothetical protein | 0.0043 | 0.0194 | 0.5 |
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0162 | 0.2514 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.4763 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0193 | 0.0769 |
Trichomonas vaginalis | Clan U, family U48, CaaX prenyl peptidase 2-like | 0.0162 | 0.2514 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0193 | 0.0769 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0208 | 0.006 |
Leishmania major | CAAX prenyl protease 2, putative,peptidase with unknown catalytic mechanism (family U48) | 0.0162 | 0.2514 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0975 | 0.3367 |
Mycobacterium ulcerans | lipase LipD | 0.0043 | 0.0194 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0043 | 0.0194 | 0.0001 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0043 | 0.0194 | 0.0407 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0043 | 0.0194 | 1 |
Entamoeba histolytica | CAAX prenyl protease family | 0.0162 | 0.2514 | 1 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0043 | 0.0194 | 0.0407 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0043 | 0.0194 | 0.0001 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0043 | 0.0194 | 0.0407 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0194 | 0.0003 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0044 | 0.0208 | 0.0063 |
Giardia lamblia | Hypothetical protein | 0.0162 | 0.2514 | 0.5 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0043 | 0.0194 | 0.0407 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0193 | 0.0769 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0044 | 0.0208 | 0.006 |
Echinococcus multilocularis | CAAX prenyl protease 2 | 0.0162 | 0.2514 | 0.2367 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0975 | 0.3367 |
Chlamydia trachomatis | hypothetical protein | 0.0034 | 0 | 0.5 |
Trypanosoma cruzi | CAAX prenyl protease 2, putative | 0.0162 | 0.2514 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0193 | 0.0769 |
Brugia malayi | beta-lactamase family protein | 0.0043 | 0.0194 | 0.0003 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0043 | 0.0194 | 0.0003 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0043 | 0.0194 | 0.0407 |
Brugia malayi | CAAX amino terminal protease family protein | 0.0162 | 0.2514 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0043 | 0.0194 | 0.0003 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0546 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0043 | 0.0194 | 0.0407 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0043 | 0.0194 | 1 |
Treponema pallidum | hypothetical protein | 0.0034 | 0 | 0.5 |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0.0194 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.2157 | 0.8462 |
Mycobacterium tuberculosis | Conserved protein | 0.0043 | 0.0194 | 0.0407 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0084 | 0.0975 | 0.3369 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.2157 | 0.8462 |
Plasmodium falciparum | protease, putative | 0.0034 | 0 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0084 | 0.0975 | 0.3369 |
Trypanosoma cruzi | peptidase with unknown catalytic mechanism (family U48) | 0.0162 | 0.2514 | 1 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0043 | 0.0194 | 0.0407 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0043 | 0.0194 | 0.0407 |
Echinococcus granulosus | geminin | 0.015 | 0.2276 | 0.2123 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.5119 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.